Compare TEVA & HUM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TEVA | HUM |
|---|---|---|
| Founded | 1901 | 1961 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2B | 28.2B |
| IPO Year | N/A | 1993 |
| Metric | TEVA | HUM |
|---|---|---|
| Price | $34.60 | $193.94 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 18 |
| Target Price | $35.50 | ★ $285.18 |
| AVG Volume (30 Days) | ★ 11.6M | 2.3M |
| Earning Date | 01-28-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 1.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.21 | ★ 10.68 |
| Revenue | $17,258,000,000.00 | ★ $126,362,000,000.00 |
| Revenue This Year | $0.63 | $10.84 |
| Revenue Next Year | $1.67 | $12.23 |
| P/E Ratio | $28.76 | ★ $18.12 |
| Revenue Growth | 4.32 | ★ 9.87 |
| 52 Week Low | $12.47 | $186.00 |
| 52 Week High | $37.35 | $315.35 |
| Indicator | TEVA | HUM |
|---|---|---|
| Relative Strength Index (RSI) | 66.83 | 24.48 |
| Support Level | $34.20 | $186.00 |
| Resistance Level | $37.35 | $196.34 |
| Average True Range (ATR) | 1.15 | 7.97 |
| MACD | 0.13 | -5.80 |
| Stochastic Oscillator | 62.90 | 5.51 |
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.